Please Wait a Moment
X

CTS History

01Dec

Babesia

SuperUser Account |01 Dec, 2015 | Return|

In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.

About the Author

Related

Source plasma partners

Source plasma partners

By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...

Read More >
Dengue Testing

Dengue Testing

CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.

Read More >
Source Plasma Testing

Source Plasma Testing

In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...

Read More >
Zika Testing

Zika Testing

In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...

Read More >

Operational Excellence

CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...

Read More >
CTS Founded

CTS Founded

In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...

Read More >